Nan Shan Life Insurance’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Buy |
+157,989
| New | +$17.5M | 0.39% | 76 |
|
|
2025
Q1 | – | Sell |
-243,792
| Closed | -$22.5M | – | 116 |
|
|
2024
Q4 | $22.5M | Sell |
243,792
-492,590
| -67% | -$45.5M | 0.54% | 62 |
|
|
2024
Q3 | $61.7M | Buy |
736,382
+96,032
| +15% | +$8.05M | 1.45% | 20 |
|
|
2024
Q2 | $43.9M | Buy |
640,350
+73,046
| +13% | +$5.01M | 1.04% | 32 |
|
|
2024
Q1 | $41.6M | Buy |
567,304
+280,288
| +98% | +$20.5M | 0.98% | 36 |
|
|
2023
Q4 | $23.3M | Sell |
287,016
-324,700
| -53% | -$26.3M | 0.56% | 57 |
|
|
2023
Q3 | $45.8M | Buy |
611,716
+196,309
| +47% | +$14.7M | 1.25% | 26 |
|
|
2023
Q2 | $32M | Buy |
415,407
+111,607
| +37% | +$8.6M | 0.77% | 45 |
|
|
2023
Q1 | $25.2M | Buy |
303,800
+245,992
| +426% | +$20.4M | 0.6% | 55 |
|
|
2022
Q4 | $4.96M | Sell |
57,808
-763,884
| -93% | -$65.6M | 0.14% | 79 |
|
|
2022
Q3 | $50.7M | Hold |
821,692
| – | – | 1.24% | 23 |
|
|
2022
Q2 | $50.8M | Buy |
821,692
+147,508
| +22% | +$9.12M | 1.07% | 29 |
|
|
2022
Q1 | $40.1M | Buy |
+674,184
| New | +$40.1M | 0.7% | 48 |
|
|
2021
Q2 | – | Sell |
-139,209
| Closed | -$9M | – | 112 |
|
|
2021
Q1 | $9M | Hold |
139,209
| – | – | 0.17% | 100 |
|
|
2020
Q4 | $8.11M | Buy |
+139,209
| New | +$8.11M | 0.17% | 98 |
|
|
2020
Q2 | – | Sell |
-220,776
| Closed | -$16.5M | – | 111 |
|
|
2020
Q1 | $16.5M | Buy |
220,776
+60,776
| +38% | +$4.54M | 0.6% | 48 |
|
|
2019
Q4 | $10.4M | Buy |
+160,000
| New | +$10.4M | 0.32% | 55 |
|